Matthew Chapman

Rare Blood Community Liaison @Novo Nordisk

Bend, OR, US

Launch of Alhemo (first in class Anti-TFPI for Hemophilia A/B with inhibitors). Influence patient use of product portfolio (NovoSeven RT, Esperoct, Novoeight, Rebinyn, Tretten) to further stimulate Hemophilia Treatment Center prescribing habits and formulary utilization. Remove barriers to product access/reimbursement through patient assistance management and prescriber/pharmacy education. Work cross functionally with rare disease team to ensure therapy access. Educate HCP’s on clinical data/patient assistance program. Support disease state Chapters for community representation and portfolio awareness. Work with Specialty Pharmacies/340B for patient education/acquisition

Oregon State University-Cascades

Liberal Arts/English